Research

Pancreatic Cancer: R&D Landscape, Market Analysis & Amplia Therapeutics (ASX: ATX) Deep Dive

As of March 2026 Table of Contents 1. Executive Summary 2. Epidemiology 3. Market Size & Forecasts 4. Diagnosis & Staging 5. Current Treatment Landscape by Line of Therapy 6. R&D Pipeline: Drugs in Active Development 7. The KRAS Revolution 8. Novel Modalities & Emerging Approaches 9. Unmet

Research

PolyNovo (ASX: PNV) — Hostile Review

PolyNovo (ASX: PNV) — Sharp Take (Bearish) March 2026 | ~A$0.92 | ~A$636M market cap What Is This Thing PolyNovo is an Australian medical device company that makes a single meaningful product: NovoSorb BTM (Biodegradable Temporising Matrix), a synthetic polyurethane foam scaffold used for dermal regeneration in burns and complex